Month: March 2022

Reflect Scientific 2021 10K Financials Show Record Profits

Written by Customer Service on March 31, 2022. Posted in Earnings Releases And Operating Results.

OREM, Utah, March 31, 2022 (GLOBE NEWSWIRE) — Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services for biotechnology, pharmaceutical, and transportation industries announces the release and SEC filing of the annual 10K financial report. “We improved margins, maintained a healthy cash flow, and increased revenue in 2021. The product R&D that was started in 2020 paid off in 2021 with an improved product that has a wider market appeal. The focus for 2022 will be on greater market penetration and a continuous product improvement process to provide our customers with the very best refrigeration solutions.” -Kim Boyce, CEO, Reflect Scientific Inc. Financial Highlights*Total revenue for the full year 2021 increased to $2.81 million compared to $2.79 million for the full year 2020, a year-over-year...

Vranken-Pommery Monopole – 2021 ANNUAL RESULTS : Strong growth in results

Written by Customer Service on March 31, 2022. Posted in Earnings Releases And Operating Results.

ANNUAL RESULTS 2021 Strong growth in resultsCONSOLIDATED TURNOVER CURRENT OPERATING INCOME EQUITY NET FINANCIAL DEBT € 301,2 million € 32,5 million € 384,3 million € 653,5 million +23,5% +72,8% +3,1% -4,4% (vs 2020) +57,2 €M +13,7 €M +11,7 €M -30,1 €M Reims, March 31, 2022 The Board of Directors of Vranken-Pommery Monopole met on March 31, 2022 under the chairmanship of Mr. Paul-François Vranken, and in the presence of the Statutory Auditors, to approve the Group’s financial statements for the year 2021. The good results for 2021 reflect the initial effects of the policy implemented by the Group since 2019. Strong growth in resultsConsolidated...

Banco Santander Chile: Announces First Quarter 2022 Analyst and Investor Webcast / Conference Call

Written by Customer Service on March 31, 2022. Posted in Public Companies.

SANTIAGO, Chile, March 31, 2022 (GLOBE NEWSWIRE) — You are cordially invited to participate in Banco Santander Chile’s (NYSE: BSAC) conference call-webcast on Friday, April 29, 2022 at 11.00 AM (Eastern Time) where we will discuss 1Q 2022 financial results. The Bank’s Officers participating in the conference call are: Emiliano Muratore, CFO, Robert Moreno, Manager of Investor Relations and Claudio Soto, Chief Economist. A question and answer session will follow the presentation. The Earnings report will be published on April 29, 2022 before the market opens. The quiet period begins on April 15. To participate, the webcast presentation can be viewed at: https://mm.closir.com/slides?id=720987 Or please dial in using any of the below numbers: United Kingdom+44 203 984 9844 USA+1 718 866 4614 Austria+43 720 022981 Brazil+556120171549...

Greenbacker delivers annual results

Written by Customer Service on March 31, 2022. Posted in Earnings Releases And Operating Results.

Company announces record growth in 2021, raises almost $1 billion in new investor capitalAtop a Greenbacker turbine The view from one of 11 turbine towers at Ridgewind, GREC’s 25-MW wind project in Murray County, MN.Key TakeawaysOperating fleet capacity nearly doubles, driving sizable production and revenue increases. Acquisition activity accelerated. Company deployed over $1.1 billion in capital; investments more than doubled. Company’s net assets nearly tripled, with almost $1 billion in new investor capital raised. Company expanded wind operations in the Midwest, driving economies of scale. Company’s investment activities continued to deliver on ESG metrics, including carbon abatement, water conservation and green jobs. Greenbacker Renewable Energy Company closed to new equity capital.NEW YORK, March 31, 2022 (GLOBE NEWSWIRE)...

Compagnie des Tramways de Rouen : Résultats de l’exercice 2021

Written by Customer Service on March 31, 2022. Posted in Earnings Releases And Operating Results.

COMPAGNIE DES TRAMWAYS DE ROUEN COMMUNIQUÉ DE PRESSERésultats de l’exercice 2021 Le 31 mars 2022Le Conseil d’Administration de Compagnie des Tramways de Rouen, réuni le 31 mars 2022, a arrêté les comptes de l’exercice 2021. Compagnie des Tramways de Rouen est une holding qui gère un portefeuille de participations. Elle n’a pas réalisé de chiffre d’affaires au cours de l’exercice 2021, comme en 2020. Après 35 milliers d’euros de charges d’exploitation, un résultat financier à 20 milliers d’euros, le résultat net ressort à -15 milliers d’euros. Proposition de dividende : 37,5 euros par action Le conseil d’administration proposera à l’Assemblée générale de verser un dividende de 37,5 euros par action au titre de l’exercice 2021, identique à celui de 2020.Chiffres de Compagnie des Tramways de Rouen(en milliers d’euros) 2021 2020Chiffre...

NEOLIFE annonce son résultat annuel 2021

Written by Customer Service on March 31, 2022. Posted in Earnings Releases And Operating Results.

NEOLIFE annonce son résultat annuel 2021 10.7 millions de CA +37% de croissance vs N-1 1er Résultat d’exploitation consolidé positif Réuni le 31 mars 2022, le Directoire a arrêté les comptes consolidés 2021 du Groupe NEOLIFE qu’il a soumis au Conseil de Surveillance pour vérification et contrôle le jour même.Compte de résultat consolidé(données en K€) 31/12/2021(audités) 31/12/2020(audités) Variation(en %)Ventes Eco-matériaux 3 496 2 258 55%Ventes Eléments de construction 7 045 5 423 30%Ventes Autres 184 152 21%Chiffre d’affaires consolidé 10 725 7 833 37% Achats consommés -7 655 -5 397 42%Marge brute 3 070 2 436 26%Taux de marge 29% 31% -2% Autres produits d’exploitation 646 546 18%Autres charges d’exploitation -3 707 -3 323 12%Dont charges externes -1 252 -1 094 14%Dont...

Quantum Genomics Announces Publication of a New Scientific Article Featuring QGC606

Written by Customer Service on March 31, 2022. Posted in Public Companies.

PARIS, March 31, 2022 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth : ALQGC, OTCQX : QNNTF), a biopharmaceutical company specializing in the development of a new drug class directly targeting the brain to treat resistant/hard-to-treat hypertension and heart failure, announced the publication of a new scientific article reporting the efficacy of its second drug-candidate, QGC606, in an experimental model of heart failure in the Canadian Journal of Cardiology. This article, entitled “QGC606, a best-in-class orally active centrally acting aminopeptidase A inhibitor prodrug, for treating heart failure following myocardial infarction,” presents the results of a study conducted with QGC606 in mice following myocardial infarction, in collaboration with the INSERM team led by Catherine Llorens-Cortes at the Collège de France and...

HII’s Mission Technologies Division Committed to Delivering Advanced Technologies and Domain Expertise

Written by Customer Service on March 31, 2022. Posted in Mergers And Acquisitions.

MCLEAN, Va., March 31, 2022 (GLOBE NEWSWIRE) — Global engineering and defense technologies provider HII (NYSE:HII) renamed its Technical Solutions division: Mission Technologies. Following a series of strategic acquisitions and supported by organic growth, the division has expanded its workforce around the globe and enhanced its capabilities with mission-critical national security solutions. “HII has transformed its portfolio across domains with highly advanced technology capabilities,” said Andy Green, executive vice president of HII and president of HII’s Mission Technologies division. “We are proud of our dedicated workforce addressing the evolving threats in support of our customers’ missions, and the name Mission Technologies underscores our offering for continued business growth.” HII’s Mission Technologies division develops...

Junshi Biosciences Announces Full Year 2021 Financial Results and Provides Corporate Updates

Written by Customer Service on March 31, 2022. Posted in Earnings Releases And Operating Results.

-Tackling the COVID-19 pandemic challenge with multi-pronged strategies – Pipeline progressed and expanded substantially SHANGHAI, China, March 31, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, today announced financial results for the full year 2021 and provided corporate updates. Full Year 2020 Financial HighlightsTotal revenue reached RMB 4,025 million in 2021, representing an increase of 152% compared to the year 2020. Revenue from out-licensing significantly increased to RMB3,341 million, which is based on two cooperation projects: 1) the research collaboration and license agreement with Lilly and Company (“Lilly”); 2)...

VAYK To Launch V-2 Of Award-Winning P2P Alt Finance APP Next Month

Written by Customer Service on March 31, 2022. Posted in Public Companies.

Dallas, Texas, March 31, 2022 (GLOBE NEWSWIRE) — Vaycaychella, Inc. (OTC Pink: VAYK) today announced the company intends to release the next version of its award winning Peer-To-Peer (P2P) Alternative Finance Application next month in April. VAYK is an early-stage business building a portfolio of technology solutions to further democratize participation in the tourism market extending more opportunity to individuals and small and medium (SMB) business operators. VAYK supports individuals and SMBs in getting into the Airbnb business. The P2P Alt Finance App is designed to support individual and SMBs gaining access to alternative purchase finance to secure short-term vacation rental properties. VAYK plans to soon publish its 2021 annual report. In conjunction with the upcoming annual report, VAYK plans to publish a detailed management...

Month: March 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice